Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Clinical Immunology · Agammaglobulinemia 5

Symptoms and Warning Signs of AGM5

At a Glance

Agammaglobulinemia 5 can cause recurrent infections of the lungs, sinuses, ears, gut, and skin because the body lacks protective antibodies. Breathing trouble, neurological changes, or signs of sepsis require immediate emergency care.

Living with Agammaglobulinemia 5 (AGM5) means your immune system lacks the B cells and antibodies needed to identify and destroy common germs. Because of this, infections are the primary way this condition shows itself [1]. While everyone gets the occasional cold, for someone with AGM5, those germs can take hold more easily and move deeper into the body [2][3].

Common Sites of Infection

Most infections in people with agammaglobulinemia occur in the “barrier” areas of the body—the lungs, the gut, and the skin—where the immune system first meets the outside world.

  • Respiratory System: This is the most common area affected. You may experience recurrent pneumonia (lung infection), sinusitis (sinus infection), or otitis (ear infection) [4]. Over time, repeated lung infections can lead to bronchiectasis, a condition where the airways become scarred and widened, making it harder to clear mucus [5][6].
  • Gastrointestinal (GI) Tract: Without antibodies in the gut, you may be prone to persistent diarrhea or infections from parasites like Giardia or bacteria like Campylobacter [7][8].
  • Skin and Soft Tissue: You might notice frequent skin infections, such as abscesses (painful collections of pus) or pyoderma (crusting skin sores), often caused by common bacteria like Staphylococcus [9].

Types of Germs to Watch For

Your immune system is specifically vulnerable to encapsulated bacteria. These germs have a protective coating that makes them “slippery” and hard for the immune system to catch without antibodies. Common examples include Streptococcus pneumoniae and Haemophilus influenzae [10][11].

Certain viruses are also a concern, particularly enteroviruses. In people with very low antibodies, these viruses can occasionally cause long-term complications in the nervous system [12][13].

A Note on Physical Features

Because the TCF3 gene is involved in early development, a few case reports have noted mild dysmorphic features (slight differences in the shape of the face) [1]. This is an uncommon and variable observation that is assessed by a genetics professional. It is not required for diagnosis and is not something you need to self-diagnose.

Knowing When to Seek Care

Because you lack your own antibodies, you should have a low threshold for contacting your immunology team [14]. Do not delay assessment simply because symptoms initially look like a viral cold. Work with your doctor to establish a clinician-approved, individualized sick-day plan.

Medical Emergencies (Call Your Local Emergency Number or Go to the ER)

Certain symptoms suggest a severe infection, such as sepsis (a body-wide reaction to infection), severe pneumonia, or meningoencephalitis (inflammation of the brain and its lining) [15][16]. Seek emergency care for:

  • Difficulty breathing: Shortness of breath at rest, chest pain, rapid breathing, low oxygen, or a blue tint to the lips or fingernails [15][17].
  • Neurological changes: A sudden, severe headache; a stiff neck; new seizures; or becoming confused or unusually sleepy [18][16]. These symptoms warrant immediate care even without a high fever.
  • Signs of Sepsis: A very high fever or a very low body temperature, accompanied by shivering, rapid heart rate, or feeling extremely ill [19][20].

Same-Day Medical Calls

Contact your immunologist or primary care doctor the same day if you experience:

  • A fever that meets your doctor’s specific threshold [14].
  • A new or worsening cough, or shortness of breath [11][15].
  • Persistent diarrhea or severe abdominal pain [7].
  • New, painful, or spreading redness on the skin [8].

Do not self-start antibiotics unless your clinician has provided an explicit, patient-specific plan. Managing AGM5 is a partnership between you and your care team. Learning your “baseline” and recognizing early warning signs is the best way to stay ahead of infections [21][22].

Common questions in this guide

What infections are common in people with AGM5?
AGM5 commonly leads to repeated infections of the lungs, sinuses, and ears, including pneumonia, sinusitis, and otitis. Persistent diarrhea and infections caused by Giardia or Campylobacter can also occur, as can skin abscesses and pyoderma.
When should someone with AGM5 go to the emergency room?
Seek emergency care for difficulty breathing, chest pain, blue lips or fingernails, low oxygen, or rapid breathing. Sudden severe headache, a stiff neck, seizures, confusion, unusual sleepiness, or signs of sepsis also require immediate care, even without a high fever.
What symptoms require a same-day call to an AGM5 care team?
Contact your immunologist or primary care clinician the same day for a fever that reaches your agreed threshold, a new or worsening cough, or shortness of breath. Persistent diarrhea, severe abdominal pain, or new painful and spreading skin redness also warrant a same-day call.
Why are enteroviruses a concern in AGM5?
People with very low antibody levels may have trouble controlling enteroviruses. In some cases, these viruses can cause lasting problems involving the nervous system, so new severe headaches, stiff neck, seizures, confusion, or unusual sleepiness need urgent evaluation.
Can repeated infections from AGM5 damage the lungs?
Yes. Repeated lung infections can lead to bronchiectasis, in which the airways become scarred and widened. This can make it harder to clear mucus and should be discussed with the immunology team.
Should I start antibiotics on my own when AGM5 symptoms begin?
Do not start antibiotics unless your clinician has given you an explicit, personalized plan. Your care team should explain which symptoms require a same-day call, which require emergency care, and how to follow your individual sick-day instructions.

Get notified when new evidence is published on agammaglobulinemia 5, autosomal dominant.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    Exclusive Characteristics of the p.E555K Dominant-Negative Variant in Autosomal Dominant E47 Deficiency.

    Utsumi T, Tsumura M, Yashiro M, et al.

    Journal of clinical immunology 2024; (44(7)):167 doi:10.1007/s10875-024-01758-x.

    PMID: 39073655
  2. 2

    Infection Phenotypes Among Patients with Primary Antibody Deficiency Mined from a US Patient Registry.

    Pickett G, Motazedi T, Kutac C, et al.

    Journal of clinical immunology 2021; (41(2)):374-381 doi:10.1007/s10875-020-00916-1.

    PMID: 33205244
  3. 3

    A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.

    Hernandez-Trujillo V, Zhou C, Scalchunes C, et al.

    Journal of clinical immunology 2023; (43(6)):1468-1477 doi:10.1007/s10875-023-01502-x.

    PMID: 37219739
  4. 4

    Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.

    Fekrvand S, Yazdani R, Olbrich P, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.

    PMID: 32058651
  5. 5

    Outcomes of X-Linked Agammaglobulinaemia Patients.

    Shillitoe B, Duque JSR, Lai SHY, et al.

    Journal of clinical immunology 2024; (45(1)):40.

    PMID: 39541002
  6. 6

    Clinical and genetic characterization of X-linked agammaglobulinemia in a Colombian cohort.

    Olaya Hernández M, Triviño Arias J, Arias Valderrama O, et al.

    The World Allergy Organization journal 2026; (19(9)):101441 doi:10.1016/j.waojou.2026.101441.

    PMID: 42733469
  7. 7

    Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.

    Pac M, Bernatowska EA, Kierkuś J, et al.

    Archives of medical science : AMS 2017; (13(2)):412-417 doi:10.5114/aoms.2016.60338.

    PMID: 28261296
  8. 8

    Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India.

    Madathil Govindaraj G, Jain A, Edavazhippurath A, et al.

    Human immunology 2022; (83(4)):335-345 doi:10.1016/j.humimm.2022.01.003.

    PMID: 35074268
  9. 9

    Adult Sibling Cases of Cutaneous Botryomycosis Leading to the Diagnosis of X-Linked Agammaglobulinemia.

    Takeuchi M, Kaku Y, Hashikawa K, et al.

    The American Journal of dermatopathology 2026; (48(8)):632-636 doi:10.1097/DAD.0000000000003306.

    PMID: 42358014
  10. 10

    X-linked agammaglobulinemia: ınvestigation of clinical and laboratory findings, novel gene mutations and prevention of ınfective complications in long-term follow-up.

    Yıldırım İ, Topyıldız E, Bilgin RBG, et al.

    American journal of clinical and experimental immunology 2021; (10(1)):37-43.

    PMID: 33815962
  11. 11

    Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report.

    Wong YX, Shyur SD

    Medicina (Kaunas, Lithuania) 2022; (58(10)) doi:10.3390/medicina58101457.

    PMID: 36295618
  12. 12

    Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy.

    Bearden D, Collett M, Quan PL, et al.

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1059-1065 doi:10.1016/j.jaip.2015.12.015.

    PMID: 26883540
  13. 13

    X-Linked Agammaglobulinemia With Chronic Meningoencephalitis: A Diagnostic Challenge.

    Saini AG, Radotra BD, Bhattarai D, et al.

    Indian pediatrics 2021; (58(2)):169-173.

    PMID: 33632949
  14. 14

    Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.

    Soresina A, Moratto D, Chiarini M, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(5)):565-569 doi:10.1111/pai.13263.

    PMID: 32319118
  15. 15

    Severe Polymicrobial Pneumonia With Septicemia After Interruption of Immunoglobulin Replacement in X-Linked Agammaglobulinemia: A Case Report.

    Tran HD, Vo QH, Nguyen NP

    Case reports in immunology 2026; (2026()):7974374 doi:10.1155/crii/7974374.

    PMID: 42729739
  16. 16

    An X-linked agammaglobulinemia (XLA) patient with fever and disturbance of consciousness: infection with Torque teno virus?

    Liu H, Zhao J, Yang L, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022; (115()):26-29 doi:10.1016/j.ijid.2021.11.041.

    PMID: 34863924
  17. 17

    A case report of X-linked agammaglobulinemia complicated with necrotic pneumonia.

    Zhang X, Zhu J

    Translational pediatrics 2026; (15(4)):160 doi:10.21037/tp-2025-353.

    PMID: 42158683
  18. 18

    Meningoencephalitis in primary antibody deficiency: Our experience from northwest India.

    Jindal AK, Chaudhary H, Tyagi R, et al.

    Journal of neuroimmunology 2022; (371()):577952 doi:10.1016/j.jneuroim.2022.577952.

    PMID: 36030644
  19. 19

    Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.

    Yeh YH, Hsieh MY, Lee WI, et al.

    Frontiers in immunology 2020; (11()):2001 doi:10.3389/fimmu.2020.02001.

    PMID: 33013854
  20. 20

    Concomitant diagnosis of immune deficiency and Pseudomonas sepsis in a 19 month old with ecthyma gangrenosum by host whole-genome sequencing.

    Sanford E, Farnaes L, Batalov S, et al.

    Cold Spring Harbor molecular case studies 2018; (4(6)) doi:10.1101/mcs.a003244.

    PMID: 30559311
  21. 21

    Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.

    Hanitsch L, Baumann U, Boztug K, et al.

    European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.

    PMID: 32845010
  22. 22

    The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.

    Baumann U, Routes JM, Soler-Palacín P, Jolles S

    Frontiers in immunology 2018; (9()):1837 doi:10.3389/fimmu.2018.01837.

    PMID: 30147696

This page is for informational purposes only and does not constitute medical advice. Ask your immunologist to create a personalized sick-day and emergency plan for AGM5 symptoms.